Australia's Patrys jumps on progress in anti-cancer drug

Patrys

15/09/2021 02:37

** Shares of Patrys Ltd  PAB.AX  rise as much as 15.4% to
A$0.045, marking their biggest intraday pct gain since Aug. 26
    ** Therapeutic antibody development co confirms https://www.asx.com.au/asxpdf/20210915/pdf/450hr6msx5kw2g.pdf
 it has been able to conjugate an anti-cancer drug called
monomethyl auristatin E (MMAE) to its full-size
    ** Stock hits highest since Sept. 3
    ** Over 17.2 mln shares change hands, vs 30-day average
volume of ~8.8 mln
    ** Stock up 62.5% YTD, as of last close

 (Reporting by Arundhati Dutta in Bengaluru)
 ((Arundhati.Dutta@thomsonreuters.com;))